CGNT vs RELX Stock Comparison

Cognyte Software and Relx Prices as of Oct 23, 2026 Peers: Industry group
CGNT Cognyte Software Ltd.
$9.76 +11.8% 1M +17.9% 1Y
Market cap
$728.01M
P/E
208.7x
Revenue (TTM)
$421.71M
Div. yield
–
Analytics and BI Technology
2 wins
RELX Relx Plc
$40.52 +22.0% 1M -11.8% 1Y
Market cap
$73.70B
P/E
–
Revenue (TTM)
—
Div. yield
–
Analytics and BI Technology
3 wins

Head to Head

5 decided of 12

Relx leads on 3 of the 12 questions below (Relx 3, Cognyte Software 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCGNTRELXLeader
Larger companyMarket capitalisation $728.01M $73.70B RELX
Cheaper on earningsLower P/E, profitable companies only 208.7x — –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 20.3x 22.5x CGNT
Faster revenue growthRevenue growth, trailing twelve months +12.0% — –
More profitableNet margin, trailing twelve months 0.8% — –
Better return on capitalReturn on invested capital — — –
Less leveragedLower net debt / EBITDA — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +17.9% -11.8% CGNT
Better 5-year returnAnnualised price return, 5 years -15.3%/yr +5.5%/yr RELX
Less volatileAnnualised volatility, 1 year 52.1% 35.2% RELX
Higher overall scoreMean of the five percentile scores vs peers 57/100 — –

Percentile Scorecard

CGNTRELX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCGNTRELX
Valuation 59 #42 of 101 –
Growth 89 #12 of 97 –
Profitability 61 #37 of 94 –
Financial Health 60 #44 of 109 18 #90 of 109
Shareholder Returns 14 #55 of 64 49 #33 of 64
Overall 57 –
  • CGNT ranked among 114 companies in Business Applications
  • RELX ranked among 114 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCGNTRELXSPY
1 month +11.8%+22.0% -1.0%
3 months +17.4%+17.7% +2.9%
6 months +1.8%+10.9% +6.4%
Year to date +3.8%+0.2% +11.4%
1 year +17.9%-11.8% +13.1%
3 years +109.4%+17.3% +79.4%
3 years, per year +28.0%+5.5% +21.5%
5 years -56.3%+30.5% +67.7%
5 years, per year -15.3%+5.5% +10.9%
10 years —+124.4% +255.2%
10 years, per year —+8.4% +13.5%

Risk

MeasureCGNTRELXSPY
Volatility, 1Y 52.1%35.2% 12.7%
Downside volatility, 1Y 56.6%36.1% 12.7%
Beta vs S&P 500, 1Y 1.300.21 1.00
Return / volatility, 1Y 0.34-0.34 1.03
Max drawdown, 5Y -89.3%-50.2% -25.4%
From 52-week high -20.3%-13.1% -2.5%
52-week high $12.24$46.64 $779.14
52-week low $6.34$27.73 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCGNTRELX
P/E now vs peer median 204.0xmedian 29.9x —median 29.9x
P/S now vs peer median 1.7xmedian 2.8x —median 2.8x
EV/EBITDA now vs peer median 20.8xmedian 17.4x —median 17.4x
P/FCF now vs peer median 24.6xmedian 16.9x —median 16.9x
P/B now vs peer median 3.2xmedian 3.1x 44.3xmedian 3.1x
PEG now vs peer median 7.57median 0.86 —median 0.86

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCGNTRELX
Revenue $421.71M –
Gross profit $307.70M –
Operating income $17.43M –
Net income $4.85M –
Free cash flow $28.96M –
R&D $127.59M –
EPS (diluted) $0.05 –
Cash & equivalents $102.17M $291.59M
Total debt – $3.11B
Shares (diluted) 72.91M 1.84B
Enterprise value $293.19M $72.79B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCGNTRELX
P/E 204.0x –
P/FCF 24.6x –
P/Operating cash flow 17.2x –
P/S 1.7x –
P/B 3.2x 44.3x
P/Tangible book 3.3x -29.9x
EV/EBITDA 20.8x –
EV/EBIT 35.1x –
EV/Revenue 1.4x –
EV/FCF 21.1x –
EV/Operating cash flow 14.8x –
PEG (3Y EPS CAGR) 7.57 –

Growth

14 metrics
MetricCGNTRELX
Revenue growth (1Y) 12.0% –
Revenue CAGR (3Y) 12.7% –
Gross profit growth (1Y) 15.3% –
Gross profit CAGR (3Y) 17.1% –
Operating income growth (1Y) 406.0% –
Operating income CAGR (3Y) 31.9% –
Net income growth (1Y) 202.7% –
Net income CAGR (3Y) 27.4% –
EPS growth (1Y) 201.4% –
EPS CAGR (3Y) 26.9% –
Operating cash flow growth (1Y) 56.8% –
Operating cash flow CAGR (3Y) 38.0% –
Free cash flow growth (1Y) 53.0% –
Free cash flow CAGR (3Y) 66.3% –

Profitability

14 metrics
MetricCGNTRELX
Gross margin 73.0% –
EBITDA margin 7.0% –
Operating margin 4.1% –
Pretax margin 3.1% –
Net margin 0.8% –
FCF margin 6.9% –
Operating cash flow margin 9.8% –
Return on equity 2.2% –
Return on assets 0.9% –
Return on invested capital – –
Return on capital employed 5.9% –
Asset turnover 0.8x –
Cash conversion (OCF / net income) 8.5x –
Stock comp / revenue 5.3% –

Financial Health

11 metrics
MetricCGNTRELX
Debt / assets – 15.6%
Debt / equity – 1.9x
Net debt / EBITDA – –
Debt / FCF – –
Liabilities / assets 56.6% 91.7%
Equity / assets 43.4% 8.3%
Interest coverage 113.9x –
Current ratio 1.3x –
Quick ratio 0.5x 0.4x
Cash ratio 0.5x 0.0x
Altman Z-score 2.18 –

Shareholder Returns

7 metrics
MetricCGNTRELX
Dividend yield – 2.2%
Net buyback yield -2.8% –
Shareholder yield -2.8% 2.2%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCGNTRELX
Forward P/E 20.3xFY2026 22.5xFY2026
EPS, next fiscal year $0.48FY2026 $1.80FY2026
EPS growth, next FY +71.4%FY2026 +2.9%FY2026
EPS growth, the year after +68.8% +20.0%
Revenue, next fiscal year $426.78MFY2026 $13.74BFY2026
Revenue growth, next FY +6.7%FY2026 +5.0%FY2026
Revenue growth, the year after +18.3% +0.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCGNTRELX
Held by institutions 67.2% 4.7%
Institutions holding 133 439
Change in shares held, QoQ -2.8% +0.2%
Institutions buying 75 220
Institutions selling 33 157
Buyers to sellers 2.27 1.40

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CGNTRELX
CGNT 1.00 0.34
RELX 0.34 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CGNT and RELX?

Relx (RELX) is the largest by market capitalisation: Cognyte Software (CGNT) $728.01M, Relx (RELX) $73.70B.

Which stock has performed better?

Over the past year Cognyte Software (CGNT) returned the most: Cognyte Software (CGNT) +17.9%, Relx (RELX) -11.8%. Over five years, Relx (RELX) compounded fastest (Cognyte Software (CGNT) -15.3%/yr, Relx (RELX) +5.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Relx (RELX) has been the steadiest (Cognyte Software (CGNT) 52.1%, Relx (RELX) 35.2%). Volatility measures how widely the price swings, not the risk of the business.

Do CGNT and RELX move together?

Their daily returns over the past year have a correlation of 0.34, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CGNT and RELX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Relx (RELX) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.